The new Schedule M will be implemented from 1 January, 2026, to help MSMEs adjust to updated manufacturing standards.

In a groundbreaking advancement toward cell therapy and regenerative medicine, the Abu Dhabi Stem Cells Center (ADSCC) has ...

The Abu Dhabi Stem Cells Center (ADSCC) in the UAE has developed clinical-grade induced pluripotent stem cells (iPSCs) that ...

Union Health Ministry extends deadline for pharmaceutical firms to comply with revised Schedule M standards by December 31, ...

CDSCO aims to eliminate spurious medicines by implementing stricter GMP compliance and risk-based inspections.

These companies now have until December 31, 2025, to comply with the improved manufacturing practices. The extension comes following requests from manufacturing units to upgrade their facilities, the ...

These include the operation and maintenance of processing facilities, complying with the codes of current good manufacturing practices, ensuring effective quality assurance and quality control systems ...

Assuring the quality of medicines requires a thorough understanding of pharmaceutical law and administration, Pharmaceutical Quality Systems (PQS) and Good Manufacturing Practice (GMP). Pharmaceutical ...

In a groundbreaking advancement toward cell therapy and regenerative medicine, the Abu Dhabi Stem Cells Centre (ADSCC) has ...